Integration of Novel Measures for Improved Classification of Type 2 Diabetes – Biostatistics Research Center (U01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This NOFO invites applications for a Biostatistics Research Center to participate in a consortium aimed at improving understanding of heterogeneity of type 2 diabetes (T2D). A separate NOFO (RFA-DK-23-019) will bring together investigative teams for integration of multiple data types, including markers of organ or tissue function, into analysis approaches for stratifying individuals T2D and developing more precise definitions of disease. The ultimate goal of this effort will be to 1) develop a broadly applicable framework for identifying subtypes of T2D; and 2) increase understanding of the physiologic drivers of T2D subtypes to guide development of more effective precision interventions.


  • Letter of Intent Due Date(s): September 26. 2023

  • Application Due Date: October 26, 2023

RFA-DK-23-020 Expiration Date October 27, 2023

Agency Website



Amount Description

Application budgets  should reflect the actual needs of the proposed project and should not exceed $1,000,000 per year in direct costs.

The scope of the proposed project should determine the project period. The maximum project period is 5 years.

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science

External Deadline

October 26, 2023